0,993  0,001  Respiratory analeptic
0,984  0,001  Analeptic
0,942  0,005  Apoptosis agonist
0,938  0,002  NOS2 expression inhibitor
0,892  0,005  Antineoplastic (breast cancer)
0,888  0,003  Muscle relaxant
0,887  0,007  Transcription factor NF kappa B inhibitor
0,862  0,004  Antineoplastic (ovarian cancer)
0,841  0,005  Antineoplastic (lung cancer)
0,824  0,005  Prostate cancer treatment
0,818  0,004  Cardiotonic
0,799  0,003  Skeletal muscle relaxant
0,810  0,014  Antiinflammatory
0,792  0,010  CYP3A4 substrate
0,783  0,005  Antineoplastic (melanoma)
0,764  0,005  Antineoplastic (cervical cancer)
0,739  0,004  UGT1A1 substrate
0,734  0,005  AR expression inhibitor
0,731  0,005  Cytotoxic
0,726  0,004  Hypoxia-inducible factor 1 alpha inhibitor
0,730  0,009  Chemopreventive
0,721  0,011  Antileukemic
0,714  0,005  UGT1A6 substrate
0,713  0,005  Nitric oxide antagonist
0,711  0,004  Diuretic
0,713  0,012  CYP2C9 substrate
0,709  0,013  TNF expression inhibitor
0,707  0,014  Antineoplastic (colorectal cancer)
0,700  0,010  Antihypercholesterolemic
0,688  0,004  UGT1A4 substrate
0,696  0,014  Antineoplastic (colon cancer)
0,679  0,007  NOS3 expression inhibitor
0,671  0,005  Antineoplastic (glioma)
0,658  0,005  Heart failure treatment
0,649  0,008  Hepatic disorders treatment
0,640  0,005  UDP-glucuronosyltransferase substrate
0,634  0,004  Interleukin 6 antagonist
0,631  0,015  Cholesterol antagonist
0,620  0,013  CYP2C19 substrate
0,598  0,004  Anesthetic
0,593  0,004  UGT1A3 substrate
0,591  0,004  UGT2B4 substrate
0,579  0,004  Contraceptive
0,593  0,024  Teratogen
0,566  0,004  Transcription factor STAT3 inhibitor
0,562  0,003  Aromatase inhibitor
0,569  0,014  Cytostatic
0,551  0,003  UGT2B15 substrate
0,549  0,002  UGT2B9 substrate
0,559  0,015  Antineoplastic (pancreatic cancer)
0,547  0,006  Antineoplastic (liver cancer)
0,546  0,005  ICAM1 expression inhibitor
0,550  0,015  Antiosteoporotic
0,538  0,005  Transcription factor STAT inhibitor
0,548  0,020  Bone diseases treatment
0,524  0,010  CYP3A4 inhibitor
0,537  0,024  Immunosuppressant
0,532  0,028  Embryotoxic
0,501  0,001  Na+ K+ transporting ATPase inhibitor
0,503  0,003  Contraceptive female
0,516  0,018  Proliferative diseases treatment
0,492  0,004  Sodium/bile acid cotransporter inhibitor
0,492  0,005  UGT2B7 substrate
0,500  0,014  Antineoplastic (glioblastoma multiforme)
0,503  0,021  Antifungal
0,486  0,010  Antineoplastic (renal cancer)
0,490  0,024  Carcinogenic
0,473  0,008  Hepatoprotectant
0,449  0,004  Postmenopausal disorders treatment
0,451  0,006  Sulfotransferase substrate
0,443  0,003  Mineralocorticoid receptor antagonist
0,442  0,006  Lipocortins synthesis antagonist
0,448  0,019  Antineoplastic (lymphoma)
0,454  0,026  UGT1A9 substrate
0,448  0,027  Sensitization
0,432  0,032  Antineoplastic (brain cancer)
0,413  0,015  P-glycoprotein inhibitor
0,406  0,010  Prostate disorders treatment
0,409  0,015  Anesthetic general
0,439  0,052  Antipruritic, allergic
0,402  0,024  Antiparasitic
0,436  0,062  Antibacterial
0,385  0,018  Antihelmintic
0,403  0,037  Apoptosis antagonist
0,397  0,035  Chemoprotective
0,391  0,031  Cardiovascular analeptic
0,395  0,036  Antioxidant
0,373  0,025  Antineoplastic (endocrine cancer)
0,352  0,007  Antifungal enhancer
0,390  0,047  Caspase 3 stimulant
0,431  0,093  Caspase 9 stimulant
0,365  0,029  Vascular (periferal) disease treatment
0,343  0,017  Prostatic (benign) hyperplasia treatment
0,375  0,049  Antihypertensive
0,331  0,018  Antineoplastic (squamous cell carcinoma)
0,350  0,039  Interleukin antagonist
0,348  0,038  Tumour necrosis factor alpha release inhibitor
0,360  0,054  CYP2D6 substrate
0,319  0,014  Neurotrophic factor enhancer
0,331  0,029  Antineoplastic (sarcoma)
0,304  0,007  Androgen antagonist
0,307  0,011  Cholesterol synthesis inhibitor
0,309  0,015  Antiviral (Influenza A)
0,294  0,005  UGT2B10 substrate
0,342  0,054  Radioprotector
0,315  0,027  Antiviral (Influenza)
0,326  0,048  Antihypoxic
0,309  0,033  Abortion inducer
0,326  0,060  Lipoprotein disorders treatment
0,314  0,052  DNA damaging
0,265  0,009  VEGF expression inhibitor
0,255  0,003  Aldosterone antagonist
0,272  0,024  Interferon gamma antagonist
0,272  0,026  Antiacne
0,300  0,058  Renal disease treatment
0,245  0,004  Androgen agonist
0,247  0,006  Arachidonic acid antagonist
0,246  0,009  Choleretic
0,305  0,068  CTGF expression inhibitor
0,238  0,013  Farnesoid X receptor antagonist
0,251  0,030  Antineoplastic (carcinoma)
0,254  0,033  Antipruritic, non-allergic
0,230  0,012  UGT2B1 substrate
0,237  0,028  Phospholipase C inhibitor
0,207  0,003  RNA-directed RNA polymerase stimulant
0,272  0,068  Antineoplastic (non-small cell lung cancer)
0,226  0,022  Antiviral (Hepatitis B)
0,220  0,018  Antineoplastic antibiotic
0,232  0,034  Hair growth stimulant
0,214  0,017  Microtubule formation inhibitor
0,200  0,004  UGT2B11 substrate
0,194  0,005  Anabolic
0,223  0,036  LDLR expression enhancer
0,253  0,068  Angiogenesis stimulant
0,271  0,086  Cardioprotectant
0,189  0,008  SULT1E1 substrate
0,224  0,044  Antiviral (Hepatitis)
0,247  0,068  Hypolipemic
0,216  0,041  Antiviral (Herpes)
0,212  0,041  Liver fibrosis treatment
0,179  0,009  Estrogen agonist
0,266  0,102  Interleukin 2 agonist
0,222  0,060  Platelet adhesion inhibitor
0,180  0,019  Pregnane X receptor agonist
0,165  0,005  Glycine receptor antagonist
0,162  0,005  Anticholelithogenic
0,169  0,013  Contraceptive male
0,172  0,017  Estrogen antagonist
0,250  0,099  CYP1A2 substrate
0,252  0,102  Metabolic disease treatment
0,246  0,098  Immunostimulant
0,155  0,008  Premenstrual syndrome treatment
0,188  0,041  Antidiarrheal
0,193  0,047  Amylase inhibitor
0,255  0,112  Antineoplastic (osteosarcoma)
0,165  0,032  Growth stimulant
0,205  0,080  Antihypertriglyceridemic
0,176  0,052  NOS3 expression enhancer
0,165  0,047  Skin whitener
0,135  0,020  Estrogen receptor beta antagonist
0,187  0,073  Mutagenic
0,172  0,058  Melanin inhibitor
0,243  0,131  Antithrombotic
0,140  0,032  Antiinfertility, female
0,135  0,028  Interleukin 2 antagonist
0,206  0,102  Aldehyde oxidase inhibitor
0,167  0,065  Urolithiasis treatment
0,106  0,004  Lipocortins synthesis agonist
0,150  0,049  DNA polymerase I inhibitor
0,209  0,109  DNA synthesis inhibitor
0,104  0,004  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,104  0,005  Postcoital contraceptive
0,145  0,047  Protein-tyrosine phosphatase 1B inhibitor
0,163  0,067  Protein-tyrosine phosphatase inhibitor
0,142  0,054  Antihemorrhagic
0,125  0,039  Toll-Like receptor 4 antagonist
0,133  0,047  Alcohol dehydrogenase substrate
0,095  0,009  Progesterone antagonist
0,132  0,047  Endometrios treatment
0,095  0,011  SULT2A1 substrate
0,146  0,063  Neurotrophic factor
0,091  0,010  Estrogen receptor alpha agonist
0,082  0,004  Progesterone agonist
0,082  0,004  Glucose-6-phosphate dehydrogenase inhibitor
0,091  0,013  Estrogen receptor beta agonist
0,086  0,011  5-Alpha-reductase inhibitor
0,161  0,088  Toxic, respiratory center
0,079  0,007  Glucocorticoid antagonist
0,208  0,138  Antineoplastic (multiple myeloma)
0,111  0,041  Antineoplastic alkaloid
0,094  0,025  Glycine receptor agonist
0,079  0,011  Acetyl-CoA transferase 2 inhibitor
0,171  0,105  Cardiodepressant
0,068  0,007  Microtubule stabilization
0,176  0,116  Antiprotozoal (Leishmania)
0,139  0,084  Adenylate cyclase stimulant
0,134  0,080  Protein kinase stimulant
0,088  0,035  CDC25A inhibitor
0,158  0,109  Antirickettsial
0,065  0,018  Estradiol 17 beta-dehydrogenase inhibitor
0,056  0,009  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,123  0,076  Antihyperlipoproteinemic
0,098  0,053  Bile acid receptor antagonist
0,156  0,111  Psychostimulant
0,056  0,012  Hypogonadism treatment
0,175  0,133  Age-related macular degeneration treatment
0,083  0,041  SULT1A2 substrate
0,084  0,043  Antibiotic
0,053  0,013  Farnesoid X receptor agonist
0,101  0,062  Hedgehog signaling inhibitor
0,090  0,052  Transcription factor NF kappa B stimulant
0,047  0,010  Tubulin agonist
0,082  0,046  Estrogen receptor alpha antagonist
0,048  0,012  Cholesterol absorption inhibitor
0,056  0,020  Opioid kappa receptor agonist
0,146  0,112  Diabetic nephropathy treatment
0,248  0,216  Antidiabetic
0,248  0,216  Cyclophilin D inhibitor
0,108  0,077  Cell adhesion inhibitor
0,064  0,037  Heme oxygenase stimulant
0,055  0,029  Anesthetic inhalation
0,058  0,032  Protein 50S ribosomal subunit inhibitor
0,130  0,106  Antinephritic
0,039  0,016  HMG CoA reductase inhibitor
0,029  0,007  Corticosteroid-like
0,123  0,102  CC chemokine 6 receptor antagonist
0,068  0,048  Andropause treatment
0,093  0,077  Expectorant
0,091  0,076  Glutathione S-transferase substrate
0,045  0,031  Parathyroid hormone antagonist
0,019  0,008  Vitamin D receptor agonist
0,018  0,008  Glucocorticoid agonist
0,028  0,018  Hedgehog signaling activator
0,095  0,086  SULT1A1 substrate
0,018  0,011  Telomerase stimulant
0,032  0,027  Antihyperaldosteronism
0,018  0,014  Apical sodium codependent bile acid transporter inhibitor
0,007  0,003  Transcortin receptor antagonist
0,019  0,018  Estrone sulfatase inhibitor
0,121  0,120  Growth hormone agonist
0,094  0,093  Carcinogenic, group 3
0,041  0,041  Potassium channel Kv1.3 blocker
0,020  0,020  Vitamin D receptor antagonist

